Former Chief Executive Officer · Enfusion, Inc. (ENFN)

Thomas Kim

FY2022 is the first fiscal year CompBrief holds for Thomas Kim as a named executive officer of Enfusion; the record below is that year, complete. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2022

$1,261,230

Salary $414,493Stock awards $200,000

4th of 4 named executive officers at Enfusion by FY2022 total.

4 named officers on file for Enfusion, FY2022

Thomas Kim’s pay file — $29

  • 1 fiscal year of pay, line by line
  • 1 equity grant, each cited to its filing

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Enfusion’s whole pay program stands against its peers

  • Enfusion’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on ENFN→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed May 1, 2023 (DEF 14A).

Free

Get Thomas Kim’s full pay file as a PDF — free

More than this page: up to 10 years of Thomas’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Thomas Kim compensation by year

Enfusion Summary Compensation Table · the one fiscal year held
In US dollars, as Enfusion reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2022
Salary$414,493
Bonus$0
Stock awards$200,000
Option awards$315,520
Non-equity incentive$0
Pension and deferred compensation$0
All other$331,217
Total$1,261,230

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Enfusion, Inc. DEF 14A filed May 1, 2023, accession 0001558370-23-007435, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Enfusion, Inc. filed document, accession 0001558370-23-007435. Every figure is read from that document and cited to the page and table it appears in. Filed May 1, 2023.

Enfusion’s named executive officers, FY2022

as the company reported each
Named executive officerRoleFY2022 total
Bronwen BastoneChief People Officer$1,864,846
Bradley HerringChief Financial Officer$1,793,045
Oleg MovchanChief Executive Officer and Director$1,657,048
Thomas Kim · this pageFormer Chief Executive Officer$1,261,230

The full Enfusion compensation record

free company brief

This page is one person within Enfusion's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Enfusion's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Thomas Kim's compensation dossier · One-time report. No refunds.